Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study
Leveraging ADAPT Biotargeting System would have significantly increased the probability of success Data presented at the ESMO World Congress on Gastrointestinal Cancer 2018 IRVING, Texas, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Ca... Diagnostics, Oncology Caris Life Sciences, ADAPT Biotargeting System, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Delivering Commitment to Find New Treatment Options for Patients Suffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018- Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of ... Devices, Interventional, Radiology, Orthopaedic, FDA Medtronic, Kyphon, Kyphon HV-R, Bone Cement, Sacral Insufficiency (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
Trial Will Investigate Company's Platform Cancer Immunotherapy in Patients with The Deadliest Form of Brain Cancer IRVINE, Calif., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- AIVITA Biomedical, a biotech company specializing in innovativ... Regenerative Medicine, Oncology, FDA AIVITA Biomedical, glioblastoma multiforme, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Belmont Instrument, LLC Announces the Acquisition of MTRE Advanced Technologies Ltd.
BILLERICA, Mass., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- Belmont Instrument, LLC ("Belmont") announced it has acquired MTRE Advanced Technologies Ltd. ("MTRE") product lines from Mennen Medical Ltd. MTRE, headquarte... Devices, Mergers & Acquisitions Belmont Instrument, MTRE Advanced Technologies, Mennen Medical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
VANCOUVER, June 20, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, ... Devices, Interventional, Cardiology Neovasc, Reducer, angina (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary(R)
BRIDGEWATER, N.J., June 20, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with Actavis Laboratories FL, Inc.... Biopharmaceuticals, Generics, Litigation Amneal Pharmaceuticals, Actavis Laboratories FL, Actavis Pharma, Rytary (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Steba Biotech's TOOKAD(R) Vascular Photodynamic Therapy Maintains Significant Reduction in Overall Progression and Conversion to Radical Therapy in Low-risk Prostate Cancer Patients at 4 Years
LUXEMBOURG, June 20, 2018 -- (Healthcare Sales & Marketing Network) -- Steba Biotech, a privately-owned biotechnology company focused on the development of innovative and minimally invasive photodynamic therapies and systems to treat cancers, today announ... Biopharmaceuticals, Urology, Oncology Steba Biotech, photodynamic therapy, TOOKAD, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2018 Category: Pharmaceuticals Source Type: news

Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Grifols Procleix Ultrio Elite assay screens for HIV-1, HCV, and HBV and detects HIV-2; the Procleix WNV assay screens for West Nile virus Both assays are approved to run on the fully automated NAT blood screening platform Procleix Panther system Thes... Diagnostics, FDA Grifols, Procleix Ultrio Elite, Procleix WNV, HIV-1, HCV (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Avantis Medical Names Matt Frushell as President and CEO, Salmaan Hameed as CTO, as Company Moves to Full Commercial Operation
Management team will work closely with PENTAX Medical to commercialize Third Eye Panoramic cancer detection device in U.S. SAN JOSE, Calif., June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Marking the company's move from development phase to... Devices, Diagnostics, Oncology, Personnel Avantis Medical Systems, PENTAX Medical, Third Eye Panoramic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Orbis Biosciences(R) announces New Management Hires with addition of Chief Licensing Officer and Vice President of Business Development
KANSAS CITY, Mo., June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Orbis Biosciences is pleased to announce and welcome Karl Strohmeier as Chief Licensing Officer and Brad Spitz as Vice President of Business Development. These two associates br... Biopharmaceuticals, Drug Delivery, Personnel Orbis Biosciences, Optimμm, Stratμm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
Now Offering Both Phenotype and Genotype Testing for Antibiotic Resistance SAN DIEGO and Irvine, Calif., June 19, 2018 -- (Healthcare Sales & Marketing Network) -- GenomeDx Biosciences and Pathnostics today announced the launch of the next generation G... Diagnostics, Oncology, Product Launch GenomeDx Biosciences, Pathnostics, prostate cancer, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Alpha Biopharma Announces Series A Financing
SHANGHAI, June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capita... Biopharmaceuticals, Oncology, Venture Capital, Personnel Alpha Biopharma, NSCLC, tyrosine kinase inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2018 Category: Pharmaceuticals Source Type: news

Albireo Appoints Jason G. Duncan as General Counsel and Secretary
BOSTON, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Jason G. Duncan as Gene... Biopharmaceuticals, Personnel Albireo Pharma, bile acid modulator, liver disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Elekta Unity, World's First High-Field MR-Linac, Receives CE Mark
STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized cancer treatment Elekta (EKTA-B.ST) earlier toda... Devices, Oncology, Radiology, Regulatory Elekta, Elekta Unity, magnetic resonance, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Arcuro Medical Receives FDA Regulatory Clearance
MISGAV, Israel, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Arcuro Medical Ltd. ("Arcuro"), a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received regu... Devices, Orthopaedic, FDA Arcuro Medical, SuperBall, meniscus repair, Meniscus tear (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Theranos Announces Management Transition
NEWARK, Calif., June 18, 2018 -- (Healthcare Sales & Marketing Network) -- The Board of Directors of Theranos, Inc., announced today that Elizabeth Holmes has stepped down as Chief Executive Officer and David Taylor, the Company's General Counsel, has bee... Diagnostics, Personnel Theranos (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
CARLSBAD, Calif., June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Damien McDevitt, Ph.D. has joined the company as chief business officer. In his role, Dr. McDevitt will serve as a... Biopharmaceuticals, Personnel Ionis Pharmaceuticals, SPINRAZA, nusinersen, TEGSEDI, inotersen, WAYLIVRA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Rheumatoid Arthritis Phase 4 Clinical Trial Data Recently Presented at the Annual European Congress of Rheumatology (EULAR 2018) Multiple Sclerosis Relapse Observational Registry Data Recently Presented at the 2018 Annual Meeting of the Consortium of Mu... Biopharmaceuticals Mallinckrodt, H.P. Acthar Gel, Rheumatoid Arthritis, Multiple Sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
STOCKHOLM, June 18, 2018 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that the Board of Directors have decided to continue the discussions with the US Food and Drug Administration (FDA) to agree on the d... Biopharmaceuticals, Oncology Medivir, remetinostat, cutaneous T-cell lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 18, 2018 Category: Pharmaceuticals Source Type: news

Medtronic Receives FDA Approval for 200mm and 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
New, Extended Balloon Lengths Enable Physicians to Efficiently Treat Long SFA Lesions DUBLIN - June 15, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for 200mm and 250mm lengths of... Devices, Interventional, FDA Medtronic, IN.PACT Admiral, Drug-Coated Balloon, peripheral artery disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news

MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
Initiation of registration study for ME-401 in patients with relapsed or refractory follicular lymphoma expected before year-end SAN DIEGO, June 15, 2018 -- (Healthcare Sales & Marketing Network) -- MEI Pharma, Inc. (NASDAQ: MEIP) a pharmaceutical comp... Biopharmaceuticals, Oncology MEI Pharma, follicular lymphoma, chronic lymphocytic lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news

ACell, Inc. Announces Ventral Hernia Data Presented at Abdominal Wall Reconstruction Conference
COLUMBIA, Md., June 15, 2018 -- (Healthcare Sales & Marketing Network) -- ACell, Inc. today announced that promising data focused on its Gentrix Surgical Matrix family of devices for use in ventral hernia repair was presented at the recent Abdominal Wall ... Devices, Surgery ACell , Gentrix Surgical Matrix, MatriStem UBM, hernia repair (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Announces New Undetectable Minimal Residual Disease Data from Phase 3 Relapsed/Refractory Chronic Lymphocytic Leukemia MURANO Trial of Venetoclax in Combination with Rituximab at 23rd European Hematology Association Annual Congress
83 percent (n=100) of 121 patients who achieved undetectable minimal residual disease (uMRD) at the end of combination therapy with VenR (n=194), maintained uMRD and were progression-free at 13.8 months of follow-up[1] uMRD response rates were consisten... Biopharmaceuticals, Oncology AbbVie, MURANO trial, venetoclax, chronic lymphocytic leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2018 Category: Pharmaceuticals Source Type: news

AbelsonTaylor Promotes IT Pro Amer Ghafari to Director of Information Technology
Chicago, June 14, 2018 -- (Healthcare Sales & Marketing Network) -- To strengthen its overall information security posture and disaster recovery strategies, AbelsonTaylor, the world's largest independent medical advertising agency, has promoted Amer Ghafar... Personnel AbelsonTaylor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

Centinel Spine Announces Lumbar Total Disc Replacement coverage by TRICARE
NEW YORK, June 14, 2018 -- (Healthcare Sales & Marketing Network) -- Centinel Spine, LLC is pleased to announce that TRICARE, the Military Health System for almost 10 million beneficiaries world-wide, has updated its coverage policy to now cover the compa... Devices, Orthopaedic, Neurosurgery, Reimbursement Centinel Spine, prodisc L, Anterior Lumbar, Total Disc Replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

New England Biolabs(R) Launches New NEBNext(R) Single Cell/Low Input RNA Library Prep Kit for Increased Transcript Detection with Ultra-low Input Amounts
IPSWICH, Mass., June 14, 2018 -- (Healthcare Sales & Marketing Network) -- New England Biolabs (NEB®) today announced the release of the NEBNext® Single Cell/Low Input RNA Library Prep Kit for Illumina®. This new kit incorporates an optimized ... Diagnostics, Product Launch New England Biolabs, NEBNext, Single Cell/Low Input, RNA Library Prep Kit (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

Varian Provides Update on Proposed Sirtex Acquisition
PALO ALTO, Calif., June 14, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it received notification from Sirtex Medical Limited (Sirtex) on June 14, 2018 that its board has determined that the proposal from CDH Invest... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, Sirtex Medical, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim(TM) Implantable Tibial Nerve Neuromodulator for Overactive Bladder
HERZLIYA, Israel, June 14, 2018 -- (Healthcare Sales & Marketing Network) -- BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today that the US Food and Drug Adm... Devices, Urology, Neurology, FDA BlueWind Medical, RENOVA iStim, overactive bladder, Tibial Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

Allergan Continues Active Board Refreshment Process
Thomas C. Freyman to Join Allergan plc Board of Directors Director Patrick O'Sullivan to Retire Four New Independent Members Added in Last 16 Months DUBLIN, June 14, 2018 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today... Biopharmaceuticals, Personnel Allergan (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy
Phase 1/2 clinical trial in patients with advanced solid tumors that have progressed on anti-PD-1/PD-L1 therapy to evaluate APX005M in combination with cabiralizumab and Opdivo Study to enroll metastatic non-small cell lung cancer (NSCLC), metastatic me... Biopharmaceuticals, Oncology Apexigen, cabiralizumab, Opdivo, NSCLC, melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

Venus Medtech Enters North American Market
First Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve in North America was Successfully Performed in Vancouver, Canada HANGZHOU, China and VANCOUVER, Canada, June 14, 2018 -- (Healthcare Sales & Marketing Network) -- On June 12, 201... Devices, Interventional, Cardiology, Product Launch Venus Medtech, VenusP-Valve, Transcatheter, Pulmonary Valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

BridgeBio Pharma Launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
PALO ALTO, Calif., June 13, 2018 -- (Healthcare Sales & Marketing Network) -- BridgeBio Pharma today announced the launch of CoA Therapeutics, a biopharmaceutical company developing novel small-molecules designed to increase Coenzyme-A (CoA) levels in gen... Biopharmaceuticals BridgeBio Pharma, CoA Therapeutics, Coenzyme-A, PKAN (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
Financing Will Enable Stride to Move Multiple Programs Towards the Clinic DURHAM, N.C., June 13, 2018 -- (Healthcare Sales & Marketing Network) -- StrideBio, Inc, a US-based company developing novel AAV vectors for in vivo gene therapies announced toda... Biopharmaceuticals, Venture Capital, Personnel StrideBio, gene therapy, gene editing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Bill & Melinda Gates Foundation, Li Ka Shing Foundation Lead New Funding Round to Expand Groundbreaking Progress in Restoring Infant Gut Microbiome and to Lay a Global Foundation for Long-Term Nutritional and Immune Health DAVIS, Calif., June 13, 2018 -... Biopharmaceuticals, Gastroenterology, Venture Capital Evolve BioSystems, microbiome, gut microbiome, Evivo (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Akonni Biosystems Announces the Appointment of Lawrence Firestone as Executive Vice President and Chief Financial Officer
Proven Visionary Leader and Financial Expert to Help Lead Akonni Through Commercialization FREDERICK, Md., June 13, 2018 -- (Healthcare Sales & Marketing Network) -- Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, ... Diagnostics, Personnel Akonni Biosystems, molecular diagnostics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
HAIFA, Israel, June 13, 2018 -- (Healthcare Sales & Marketing Network) -- Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems") announced today that it's subsidiary, Beyeonics Surgical Ltd. ("Beyeonics"), concluded a first r... Devices, Surgery, Venture Capital Elbit Systems, Beyeonics Surgical, Clarity Bionic Visualization (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2018 Category: Pharmaceuticals Source Type: news

NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
Optimized surface technology promotes bone growth without added growth factors SAN DIEGO, June 12, 2018 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine... Devices, Orthopaedic, Neurosurgery, Product Launch NuVasive, AttraX Scaffold, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

Artelo Biosciences Enters Into Global RandD Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology
LA JOLLA, Calif., June 12, 2018 -- (Healthcare Sales & Marketing Network) -- Artelo Biosciences, Inc. (OTCQB: ARTL), a biopharmaceutical company focused on the development of therapeutic treatments that modulate the endocannabinoid system, today announced... Biopharmaceuticals, Oncology Artelo Biosciences, Syngene, ART27.13 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

MicroVention Announces FDA Clearance For Thrombectomy Device
SOFIA® Catheter; A New Device for the Revascularization of Patients with Acute Ischemic Stroke ALISO VIEJO, Calif., June 12, 2018 -- (Healthcare Sales & Marketing Network) -- MicroVention, Inc. a U.S.-based subsidiary of Terumo and a global neurova... Devices, Interventional, Neurology, FDA MicroVention, Terumo, SOFIA Catheter, stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
MINNEAPOLIS, June 12, 2018 -- (Healthcare Sales & Marketing Network) -- Vergent Bioscience, a cancer-focused biotechnology company, announced today that it raised $8.7 million in a Series A financing round led by Spring Mountain Capital to fund its precli... Diagnostics, Oncology, Venture Capital Spring Mountain Capital, Vergent Bioscience, fluorescent probe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease
Independent data monitoring committee advises lanabecestat is unlikely to meet primary endpoints, leading to decision to discontinue these trials INDIANAPOLIS, June 12, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY)... Biopharmaceuticals, Neurology Eli Lilly, AstraZeneca, lanabecestat, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2018 Category: Pharmaceuticals Source Type: news

OrthoSensor, Inc. Secures Additional 510(K) Clearance
VERASENSE¬ô SENSOR-ASSISTED TECHNOLOGY NOW APPROVED FOR USE WITH ZIMMER BIOMET PERSONA® KNEE SYSTEM VERASENSE enables surgeons to improve knee balance and customize implant position during surgery by using intraoperative sensor data DANIA BEACH, F... Devices, Orthopaedic, FDA OrthoSensor, VERASENSE, Zimmer Biomet, Persona Knee, total knee (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Bionik Laboratories Appoints Renaud Maloberti as Chief Commercial Officer
Industry veteran brings extensive experience driving revenue growth while enhancing operational efficiencies and market leadership TORONTO and BOSTON, June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Bionik Laboratories Corp. (OTCQB: BNKL) (&... Devices, Orthopaedic, Personnel Bionik Laboratories, lower extremity rehabilitation, stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
VANCOUVER, June 11, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, ... Devices, Cardiology, Personnel Neovasc , Reducer, Tiara, transcatheter, mitral valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors
WOBURN, Massachusetts, June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today it has appointed Hyam I. Levitsky, M.D. to the company's ... Biopharmaceuticals, Oncology, Personnel Replimune, Immulytic, immunotherapy, immunotherapeutic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
CoaguChek® Vantus system enables wireless reporting of INR results, making it easier for patients to accurately report their results INDIANAPOLIS, June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announc... Devices, Monitoring, Product Launch Roche Group, CoaguChek, Vantus, coagulation, Warfarin, coumadin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Propeller Health Raises Strategic Investment from McKesson Ventures
MADISON, Wis., June 11, 2018 -- (Healthcare Sales & Marketing Network) -- Propeller Health, a leading digital therapeutics company, announced a strategic investment of an undisclosed amount from McKesson Ventures, adding to the $20M funding round announce... Devices, Venture Capital Propeller Health, digital therapeutics, digital medicines, Asthma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
COPENHAGEN, Denmark, June 11, 2018 -- (Healthcare Sales & Marketing Network) -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies, based on its proprietary T-win technology, today announced th... Biopharmaceuticals, Oncology, Personnel IO Biotech, T-Win, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 11, 2018 Category: Pharmaceuticals Source Type: news

Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
BOSTON, June 08, 2018 -- (Healthcare Sales & Marketing Network) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the election of Anne Klibanski, M.D., and ... Biopharmaceuticals, Gastroenterology, Personnel Albireo Pharma, bile acid modulator, liver disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 8, 2018 Category: Pharmaceuticals Source Type: news

European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Third Indication in Europe for Prolia for the Treatment of Patients at Increased Risk of Fractures THOUSAND OAKS, Calif., June 8, 2018 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) h... Biopharmaceuticals, Regulatory Amgen, Prolia , denosumab, osteoporosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 8, 2018 Category: Pharmaceuticals Source Type: news